To assess the usefulness of circulating microRNAs (miRNAs) as non-invasive molecular
biomarkers for early prediction of preeclampsia, a differential miRNA profiling analysis was …

The present study aimed to identify the differential expression profiles of microRNAs in the
plasma between patients with preeclampsia (PE) and healthy pregnancies using …

Abstract Objective To identify microRNAs (miRNAs) differentially expressed at early stages
of gestation (12–14 weeks) in the serum of pregnant women, who later developed severe …

Preeclampsia (PE) is a pregnancy syndrome characterized by hypertension and proteinuria,
and a leading cause of maternal and fetal morbidity and mortality, with poorly defined …

microRNAs are important regulators of cell processes and have been proposed as potential
preeclampsia biomarkers. We evaluated serum microRNA expression profiling to identify …

Until recently, the molecular pathogenesis of preeclampsia (PE) remained largely unknown.
Reports have shown that circulating microRNAs (miRNAs) are promising novel biomarkers …

Preeclampsia is a pregnancy complication associated with angiogenic dysbalance,
maternal endothelial dysfunction and end-organ injury. A predictive test to identify those who …

Objective We carried out a meta-analysis to quantitatively summarize the overall diagnostic
and predictive effects of circulating microRNAs in diagnosis and prediction of preeclampsia …

Pre-eclampsia (PE) is a common hypertensive disorder of pregnancy with a significant
impact on maternal and neonatal mortality and morbidity. While the pathogenesis of PE has …

To identify the specific serum preeclampsia (PE)-related biomarkers, 10 microRNAs
(miRNAs) were selected based on their reported aberrant (4 upregulated and 6 …